{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:35:27Z","timestamp":1790102127743,"version":"4.0.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12015-025-10912-w","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:42:45Z","timestamp":1750221765000},"page":"1611-1630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-Term Results of Hematopoietic Cell Transplantation (HCT) for Adults with Blood Disorders\u2013 A Systematic Review"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2112-1698","authenticated-orcid":false,"given":"Kajetan","family":"Karaszewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3299-8143","authenticated-orcid":false,"given":"Jakub","family":"G\u00f3ra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9754-8001","authenticated-orcid":false,"given":"Weronika","family":"Ploch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6813-3331","authenticated-orcid":false,"given":"Wies\u0142aw Wiktor","family":"J\u0119drzejczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"issue":"8","key":"10912_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","volume":"57","author":"JA Snowden","year":"2022","unstructured":"Snowden, J. A., S\u00e1nchez-Ortega, I., Corbacioglu, S., Basak, G. W., Chabannon, C., de la Camara, R., Dolstra, H., Duarte, R. F., Glass, B., Greco, R., Lankester, A. C., Mohty, M., Neven, B., de Latour, R. P., Pedrazzoli, P., Peric, Z., Yakoub-Agha, I., Sureda, A., Kr\u00f6ger, N., European Society for Blood and Marrow Transplantation (EBMT). (2022). Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe 2022. Bone Marrow Transplant,57(8), 1217\u20131239. https:\/\/doi.org\/10.1038\/s41409-022-01691-w","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10912_CR2","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.bbmt.2020.03.002","volume":"26","author":"AS Kanate","year":"2020","unstructured":"Kanate, A. S., Majhail, N. S., Savani, B. N., Bredeson, C., Champlin, R. E., Crawford, S., Giralt, S. A., LeMaistre, C. F., Marks, D. I., Omel, J. L., Orchard, P. J., Palmer, J., Saber, W., Veys, P. A., Carpenter, P. A., & Hamadani, M. (2020). Indications for hematopoietic cell transplantation and immune effector cell therapy: Guidelines from the american society for transplantation and cellular therapy. Biology of Blood and Marrow Transplantation,26(7), 1247\u20131256. https:\/\/doi.org\/10.1016\/j.bbmt.2020.03.002","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10912_CR3","doi-asserted-by":"publisher","unstructured":"Gratwohl, A., Pasquini, M. C., Aljurf, M., Atsuta, Y., Baldomero, H., Foeken, L., Gratwohl, M., Bouzas, L. F., Confer, D., Frauendorfer, K., Gluckman, E., Greinix, H., Horowitz, M., Iida, M., Lipton, J., Madrigal, A., Mohty, M., Noel, L., Novitzky, N,\u2026, & Niederwieser, D.; Worldwide Network for Blood and Marrow Transplantation (WBMT). (2015). One million haemopoietic stem-cell transplants: A retrospective observational study.The Lancet Haematology, 2(3):e91\u2013100. https:\/\/doi.org\/10.1016\/S2352-3026(15)00028-9","DOI":"10.1016\/S2352-3026(15)00028-9"},{"key":"10912_CR4","doi-asserted-by":"publisher","unstructured":"Niederwieser, D., Baldomero, H., Bazuaye, N., Bupp, C., Chaudhri, N., Corbacioglu, S., Elhaddad, A., Frutos, C., Galeano, S., Hamad, N., Hamidieh, A. A., Hashmi, S., Ho, A., Horowitz, M. M., Iida, M., Jaimovich, G., Karduss, A., Kodera, Y., Kr\u00f6ger, N.,\u2026, & Saber W. (2022). One and a half million hematopoietic stem cell transplants: Continuous and differential improvement in worldwide access with the use of non-identical family donors.Haematologica, 107(5):1045\u20131053. https:\/\/doi.org\/10.3324\/haematol.2021.279189","DOI":"10.3324\/haematol.2021.279189"},{"key":"10912_CR5","doi-asserted-by":"publisher","unstructured":"Cusatis, R., Litovich, C., Feng, Z., Allbee-Johnson, M., Kapfhammer, M., Mattila, D., Akinola, I., Phelan, R., Broglie, L., Auletta, J. J., Steinert, P., Bolon, Y. T., Akhtar, O., Bloomquist, J., Chen, M., Devine, S. M., Bupp, C., Hamadani, M., Hengen, M.,\u2026, & Shaw BE. (2024). Current trends and outcomes in cellular therapy activity in the united states, including prospective patient-reported outcomes data collection in the center for international blood and marrow transplant research registry.Transplantation and Cellular Therapy, 30(9):917.e1\u2013917.e12. https:\/\/doi.org\/10.1016\/j.jtct.2024.06.021","DOI":"10.1016\/j.jtct.2024.06.021"},{"issue":"1","key":"10912_CR6","doi-asserted-by":"publisher","first-page":"2343164","DOI":"10.1080\/16078454.2024.2343164","volume":"29","author":"H Li","year":"2024","unstructured":"Li, H., Zheng, Y., Gao, K., & Tian, C. (2024). Tandem autologous hematopoietic stem cell transplantation for patients with multiple myeloma: A systematic review and meta-analysis. Hematology,29(1), 2343164. https:\/\/doi.org\/10.1080\/16078454.2024.2343164","journal-title":"Hematology"},{"issue":"8","key":"10912_CR7","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.bbmt.2007.04.006","volume":"13","author":"J Kuruvilla","year":"2007","unstructured":"Kuruvilla, J., Shepherd, J. D., Sutherland, H. J., Nevill, T. J., Nitta, J., Le, A., Forrest, D. L., Hogge, D. E., Lavoie, J. C., Nantel, S. H., Toze, C. L., Smith, C. A., Barnett, M. J., & Song, K. W. (2007). Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma. Biology of Blood and Marrow Transplantation,13(8), 925\u2013931. https:\/\/doi.org\/10.1016\/j.bbmt.2007.04.006","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10912_CR8","doi-asserted-by":"publisher","unstructured":"Garderet, L., Gras, L., Koster, L., Baaij, L., Hamad, N., Dsouza, A., Estrada-Merly, N., Hari, P., Saber, W., Cowan, A. J., Iida, M., Okamoto, S., Takamatsu, H., Mizuno, S., Kawamura, K., Kodera, Y., Ko, B. S., Liam, C., Ho, K. W.,\u2026, & Niederwieser, D. (2024). Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT).American Journal of Hematology, 99(11):2084\u20132095. https:\/\/doi.org\/10.1002\/ajh.27451","DOI":"10.1002\/ajh.27451"},{"key":"10912_CR9","doi-asserted-by":"publisher","unstructured":"Attal, M., Harousseau, J. L., Facon, T., Guilhot, F., Doyen, C., Fuzibet, J. G., Monconduit, M., Hulin, C., Caillot, D., Bouabdallah, R., Voillat, L., Sotto, J. J., Grosbois, B., Bataille, R.; InterGroupe Francophone du My\u00e9lome. (2003). Single versus double autologous stem-cell transplantation for multiple myeloma.New England Journal of Medicine, 349(26):2495\u2013502. https:\/\/doi.org\/10.1056\/NEJMoa032290","DOI":"10.1056\/NEJMoa032290"},{"issue":"7","key":"10912_CR10","doi-asserted-by":"publisher","first-page":"367.e1","DOI":"10.1016\/j.jtct.2022.04.022","volume":"28","author":"C Ladbury","year":"2022","unstructured":"Ladbury, C., Somlo, G., Dagis, A., Yang, D., Armenian, S., Song, J. Y., Sahebi, F., Spielberger, R., Popplewell, L., Parker, P., Forman, S., Snyder, D., Rincon, A., Liu, A., Frankel, P., & Wong, J. (2022). Long-term follow-up of multiple myeloma patients treated with tandem autologous transplantation following melphalan and upon recovery, total marrow irradiation. Transplantation and Cellular Therapy,28(7), 367.e1-367.e9. https:\/\/doi.org\/10.1016\/j.jtct.2022.04.022","journal-title":"Transplantation and Cellular Therapy"},{"issue":"8","key":"10912_CR11","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.transproceed.2014.09.053","volume":"46","author":"G Charlinski","year":"2014","unstructured":"Charlinski, G., Ziarkiewicz, M., Boguradzki, P., Wiater, E., Torosian, T., Dwilewicz-Trojaczek, J., & Wiktor-Jedrzejczak, W. (2014). High-dose melphalan and autologous hematopoietic stem cell transplantation in primary amyloidosis: Single-center results. Transplantation Proceedings,46(8), 2877\u20132881. https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.053","journal-title":"Transplantation Proceedings"},{"issue":"7","key":"10912_CR12","doi-asserted-by":"publisher","first-page":"880","DOI":"10.4065\/81.7.880","volume":"81","author":"DH Vesole","year":"2006","unstructured":"Vesole, D. H., P\u00e9rez, W. S., Akasheh, M., Boudreau, C., Reece, D. E., Bredeson, C. N., Plasma Cell Disorders Working Committee of the Center for International Blood and Marrow Transplant Research. (2006). High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: A center for international blood and marrow transplant research study. InMayo Clinic Proceedings,81(7), 880\u20138. https:\/\/doi.org\/10.4065\/81.7.880","journal-title":"InMayo Clinic Proceedings"},{"issue":"2","key":"10912_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.beha.2016.08.018","volume":"29","author":"R Chakraborty","year":"2016","unstructured":"Chakraborty, R., Muchtar, E., & Gertz, M. A. (2016). The role of stem cell transplantation in Waldenstrom\u2019s macroglobulinemia. Best Practice & Research Clinical Haematology,29(2), 229\u2013240. https:\/\/doi.org\/10.1016\/j.beha.2016.08.018","journal-title":"Best Practice & Research Clinical Haematology"},{"issue":"Suppl 4","key":"10912_CR14","doi-asserted-by":"publisher","first-page":"iv19","DOI":"10.1093\/annonc\/mdy080","volume":"29","author":"DA Eichenauer","year":"2018","unstructured":"Eichenauer, D. A., Aleman, B. M. P., Andr\u00e9, M., Federico, M., Hutchings, M., Illidge, T., Engert, A., Ladetto, M., ESMO Guidelines Committee. (2018). Hodgkin lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology,29(Suppl 4), iv19\u2013iv29. https:\/\/doi.org\/10.1093\/annonc\/mdy080","journal-title":"Annals of Oncology"},{"key":"10912_CR15","doi-asserted-by":"publisher","unstructured":"Czyz, J., Dziadziuszko, R., Knopinska-Postuszuy, W., Hellmann, A., Kachel, L., Holowiecki, J., Gozdzik, J., Hansz, J., Avigdor, A., Nagler, A., Osowiecki, M., Walewski, J., Mensah, P., Jurczak, W., Skotnicki, A., Sedzimirska, M., Lange, A., Sawicki, W., Sulek, K.,\u2026, & Warzocha, K. (2004) Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: A study of 341 patients. Annals of Oncology, 15(8):1222\u201330. https:\/\/doi.org\/10.1093\/annonc\/mdh304","DOI":"10.1093\/annonc\/mdh304"},{"issue":"7","key":"10912_CR16","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/annonc\/mdn052","volume":"19","author":"B Sirohi","year":"2008","unstructured":"Sirohi, B., Cunningham, D., Powles, R., Murphy, F., Arkenau, T., Norman, A., Oates, J., Wotherspoon, A., & Horwich, A. (2008). Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin\u2019s lymphoma. Annals of Oncology,19(7), 1312\u20131319. https:\/\/doi.org\/10.1093\/annonc\/mdn052","journal-title":"Annals of Oncology"},{"issue":"4","key":"10912_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3324\/haematol.2015.136408","volume":"101","author":"D Sibon","year":"2016","unstructured":"Sibon, D., Morschhauser, F., Resche-Rigon, M., Ghez, D., Dupuis, J., Mar\u00e7ais, A., Deau-Fischer, B., Bouabdallah, R., Sebban, C., Salles, G., & Brice, P. (2016). Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA\/SFGM-TC study group. Haematologica,101(4), 474\u2013481. https:\/\/doi.org\/10.3324\/haematol.2015.136408","journal-title":"Haematologica"},{"issue":"1","key":"10912_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3324\/haematol.13484","volume":"94","author":"AM Carella","year":"2009","unstructured":"Carella, A. M., Bellei, M., Brice, P., Gisselbrecht, C., Visani, G., Colombat, P., Fabbiano, F., Donelli, A., Luminari, S., Feugier, P., Browett, P., Hagberg, H., & Federico, M. (2009). High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin\u2019s lymphoma responding to front-line therapy: Long-term results. Haematologica,94(1), 146\u2013148. https:\/\/doi.org\/10.3324\/haematol.13484","journal-title":"Haematologica"},{"issue":"6","key":"10912_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.bbmt.2013.03.008","volume":"19","author":"M Karuturi","year":"2013","unstructured":"Karuturi, M., Hosing, C., Fanale, M., Medeiros, L. J., Alousi, A. M., de Lima, M. J., Qazilbash, M. H., Kebriaei, P., Younes, A., Khouri, I., Andersson, B. S., Champlin, R., Anderlini, P., & Popat, U. (2013). High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma. Biology of Blood and Marrow Transplantation,19(6), 991\u2013994. https:\/\/doi.org\/10.1016\/j.bbmt.2013.03.008","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"1","key":"10912_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ajh.24927","volume":"93","author":"S Akhtar","year":"2018","unstructured":"Akhtar, S., Montoto, S., Boumendil, A., Finel, H., Masszi, T., Jindra, P., Nemet, D., Fuhrmann, S., Beguin, Y., Castagna, L., Ferrara, F., Capria, S., Malladi, R., Moraleda, J. M., Bloor, A., Ghesqui\u00e8res, H., Meissner, J., Sureda, A., & Dreger, P. (2018). High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party. American Journal of Hematology,93(1), 40\u201346. https:\/\/doi.org\/10.1002\/ajh.24927","journal-title":"American Journal of Hematology"},{"key":"10912_CR21","doi-asserted-by":"publisher","unstructured":"Berning, P., Fekom, M., Ngoya, M., Goldstone, A. H., Dreger, P., Montoto, S., Finel, H., Shumilov, E., Chevallier, P., Blaise, D., Str\u00fcssmann, T., Carpenter, B., Forcade, E., Castilla-Llorente, C., Trneny, M., Ghesquieres, H., Capria, S., Thieblemont, C., Blau, I. W.,\u2026, & Schmitz, N. (2024). Hematopoietic stem cell transplantation for DLBCL: A report from the European society for blood and marrow transplantation on more than 40,000 patients over 32 years. Blood Cancer Journal, 14(1):106. https:\/\/doi.org\/10.1038\/s41408-024-01085-9","DOI":"10.1038\/s41408-024-01085-9"},{"key":"10912_CR22","doi-asserted-by":"publisher","unstructured":"Myers, R. M., Hill, B. T., Shaw, B. E., Kim, S., Millard, H. R., Battiwalla, M., Majhail, N. S., Buchbinder, D., Lazarus, H. M., Savani, B. N., Flowers, M. E. D., D\u2019Souza, A., Ehrhardt, M. J., Langston, A., Yared, J. A., Hayashi, R. J., Daly, A., Olsson, R. F., Inamoto, Y.,\u2026, & Satwani, P. (2018). Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.Cancer, 124(4):816\u2013825. https:\/\/doi.org\/10.1002\/cncr.31114","DOI":"10.1002\/cncr.31114"},{"issue":"7","key":"10912_CR23","doi-asserted-by":"publisher","first-page":"FSO322","DOI":"10.4155\/fsoa-2018-0049","volume":"4","author":"A Galaznik","year":"2018","unstructured":"Galaznik, A., Huelin, R., Stokes, M., Guo, Y., Hoog, M., Bhagnani, T., Bell, J., & Shou, Y. (2018). Systematic review of therapy used in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma. Future Science OA,4(7), FSO322. https:\/\/doi.org\/10.4155\/fsoa-2018-0049","journal-title":"Future Science OA"},{"key":"10912_CR24","doi-asserted-by":"publisher","unstructured":"Soussain, C., Ferreri, A. J. M. (2020) Primary central nervous system lymphoma: Consolidation strategies.Annals of Lymphoma, 4(14). https:\/\/doi.org\/10.21037\/aol-20-29","DOI":"10.21037\/aol-20-29"},{"issue":"2","key":"10912_CR25","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1182\/blood-2004-04-1532","volume":"105","author":"A Krishnan","year":"2005","unstructured":"Krishnan, A., Molina, A., Zaia, J., Smith, D., Vasquez, D., Kogut, N., Falk, P. M., Rosenthal, J., Alvarnas, J., & Forman, S. J. (2005). Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood,105(2), 874\u2013878. https:\/\/doi.org\/10.1182\/blood-2004-04-1532","journal-title":"Blood"},{"issue":"1","key":"10912_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.beha.2017.10.009","volume":"31","author":"G Hess","year":"2018","unstructured":"Hess, G. (2018). The role of stem cell transplantation in follicular lymphoma. Best Practice & Research Clinical Haematology,31(1), 31\u201340. https:\/\/doi.org\/10.1016\/j.beha.2017.10.009","journal-title":"Best Practice & Research Clinical Haematology"},{"issue":"8","key":"10912_CR27","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1182\/blood-2006-03-013193","volume":"108","author":"C Sebban","year":"2006","unstructured":"Sebban, C., Mounier, N., Brousse, N., Belanger, C., Brice, P., Haioun, C., Tilly, H., Feugier, P., Bouabdallah, R., Doyen, C., Salles, G., & Coiffier, B. (2006). Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: The GELF-94 randomized study from the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA). Blood,108(8), 2540\u20132544. https:\/\/doi.org\/10.1182\/blood-2006-03-013193","journal-title":"Blood"},{"issue":"2","key":"10912_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000353778","volume":"131","author":"J Yin","year":"2014","unstructured":"Yin, J., Wei, J., Xu, J. H., Xiao, Y., & Zhang, Y. C. (2014). Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: Results of a comprehensive meta-analysis. Acta Haematologica,131(2), 114\u2013125. https:\/\/doi.org\/10.1159\/000353778","journal-title":"Acta Haematologica"},{"issue":"5","key":"10912_CR29","doi-asserted-by":"publisher","first-page":"e219807","DOI":"10.1001\/jamanetworkopen.2021.9807","volume":"4","author":"J Du","year":"2021","unstructured":"Du, J., Yu, D., Han, X., Zhu, L., & Huang, Z. (2021). Comparison of allogeneic stem cell transplant and autologous stem cell transplant in refractory or relapsed peripheral T-cell lymphoma: A systematic review and meta-analysis. JAMA Network Open,4(5), e219807. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.9807","journal-title":"JAMA Network Open"},{"issue":"4","key":"10912_CR30","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1046\/j.1365-2141.2000.02098.x","volume":"109","author":"E Deconinck","year":"2000","unstructured":"Deconinck, E., Lamy, T., Foussard, C., Gaillard, F., Delwail, V., Colombat, P., Casassus, P., Lemevel, A., Brion, A., & Milpied, N. (2000). Autologous stem cell transplantation for anaplastic large-cell lymphomas: Results of a prospective trial. British Journal of Haematology,109(4), 736\u2013742. https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02098.x","journal-title":"British Journal of Haematology"},{"key":"10912_CR31","doi-asserted-by":"publisher","unstructured":"Fenske, T. S., Zhang, M. J., Carreras, J., Ayala, E., Burns, L. J., Cashen, A., Costa, L. J., Freytes, C. O., Gale, R. P., Hamadani, M., Holmberg, L. A., Inwards, D. J., Lazarus, H. M., Maziarz, R. T., Munker, R., Perales, M. A., Rizzieri, D. A., Schouten, H. C., Smith, S. M.,\u2026, & Hari, P. N. (2014). Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.Journal of Clinical Oncology, 32(4), 273\u201381. https:\/\/doi.org\/10.1200\/JCO.2013.49.2454","DOI":"10.1200\/JCO.2013.49.2454"},{"issue":"7","key":"10912_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ajh.20646","volume":"81","author":"N Laudi","year":"2006","unstructured":"Laudi, N., Arora, M., Burns, L., McGlave, P., Miller, J., Bohac, G., Rogers, T., Barker, J., Coad, J., & Weisdorf, D. (2006). Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma. American Journal of Hematology,81(7), 519\u2013524. https:\/\/doi.org\/10.1002\/ajh.20646","journal-title":"American Journal of Hematology"},{"issue":"2","key":"10912_CR33","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/cam4.5039","volume":"12","author":"A Nagler","year":"2023","unstructured":"Nagler, A., Galimard, J. E., Labopin, M., Blaise, D., Arcese, W., Trisolini, S. M., Wu, D., Pigneux, A., Van Gorkom, G., Rubio, M. T., Gedde-Dahl, T., Huynh, A., Lanza, F., Gorin, N. C., & Mohty, M. (2023). Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT. Cancer Medicine,12(2), 1482\u20131491. https:\/\/doi.org\/10.1002\/cam4.5039","journal-title":"Cancer Medicine"},{"issue":"12","key":"10912_CR34","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.bbmt.2006.07.015","volume":"12","author":"AD Chantry","year":"2006","unstructured":"Chantry, A. D., Snowden, J. A., Craddock, C., Peggs, K., Roddie, C., Craig, J. I., Orchard, K., Towlson, K. E., Pearce, R. M., Marks, D. I., BSBMT Clinical Trials Committee. (2006). Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: A British society of blood and marrow transplantation registry study. Biology of Blood and Marrow Transplantation,12(12), 1310\u20137. https:\/\/doi.org\/10.1016\/j.bbmt.2006.07.015","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"1","key":"10912_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.blre.2006.03.002","volume":"21","author":"T de Witte","year":"2007","unstructured":"de Witte, T., Oosterveld, M., & Muus, P. (2007). Autologous and allogeneic stem cell transplantation for myelodysplastic syndrome. Blood Reviews,21(1), 49\u201359. https:\/\/doi.org\/10.1016\/j.blre.2006.03.002","journal-title":"Blood Reviews"},{"issue":"4","key":"10912_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1053\/j.seminhematol.2007.08.006","volume":"44","author":"T de Witte","year":"2007","unstructured":"de Witte, T., Suciu, S., Brand, R., Muus, P., & Kr\u00f6ger, N. (2007). Autologous stem cell transplantation in myelodysplastic syndromes. Seminars in Hematology,44(4), 274\u2013277. https:\/\/doi.org\/10.1053\/j.seminhematol.2007.08.006","journal-title":"Seminars in Hematology"},{"issue":"1","key":"10912_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ctrv.2006.10.002","volume":"33","author":"CML Autograft Trials Collaboration","year":"2007","unstructured":"CML Autograft Trials Collaboration. (2007). Autologous stem cell transplantation in chronic myeloid leukaemia: A meta-analysis of six randomized trials. Cancer Treatment Reviews,33(1), 39\u201347. https:\/\/doi.org\/10.1016\/j.ctrv.2006.10.002","journal-title":"Cancer Treatment Reviews"},{"issue":"3","key":"10912_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.annonc.2020.11.014","volume":"32","author":"MA Dimopoulos","year":"2021","unstructured":"Dimopoulos, M. A., Moreau, P., Terpos, E., Mateos, M. V., Zweegman, S., Cook, G., Delforge, M., H\u00e1jek, R., Schjesvold, F., Cavo, M., Goldschmidt, H., Facon, T., Einsele, H., Boccadoro, M., San-Miguel, J., Sonneveld, P., Mey, U., EHA Guidelines Committee; ESMO Guidelines Committee. (2021). Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Annals of Oncology,32(3), 309\u2013322. https:\/\/doi.org\/10.1016\/j.annonc.2020.11.014","journal-title":"Annals of Oncology"},{"issue":"9","key":"10912_CR39","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/sj.bmt.1701459","volume":"22","author":"J Mehta","year":"1998","unstructured":"Mehta, J., & Singhal, S. (1998). Graft-versus-myeloma. Bone Marrow Transplantation,22(9), 835\u2013843. https:\/\/doi.org\/10.1038\/sj.bmt.1701459","journal-title":"Bone Marrow Transplantation"},{"issue":"9","key":"10912_CR40","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1182\/blood-2008-02-141598","volume":"112","author":"L Rosi\u00f1ol","year":"2008","unstructured":"Rosi\u00f1ol, L., P\u00e9rez-Sim\u00f3n, J. A., Sureda, A., de la Rubia, J., de Arriba, F., Lahuerta, J. J., Gonz\u00e1lez, J. D., D\u00edaz-Mediavilla, J., Hern\u00e1ndez, B., Garc\u00eda-Frade, J., Carrera, D., Le\u00f3n, A., Hern\u00e1ndez, M., Abell\u00e1n, P. F., Bergua, J. M., San Miguel, J., Blad\u00e9, J., Programa para el Estudio y la Terap\u00e9utica de las Hemopat\u00edas Malignas y Grupo Espa\u00f1ol de Mieloma (PETHEMA\/GEM). (2008). A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma. Blood,112(9), 3591\u20133. https:\/\/doi.org\/10.1182\/blood-2008-02-141598","journal-title":"Blood"},{"issue":"2","key":"10912_CR41","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3324\/haematol.2011.045757","volume":"97","author":"A Sureda","year":"2012","unstructured":"Sureda, A., Canals, C., Arranz, R., Caballero, D., Ribera, J. M., Brune, M., Passweg, J., Martino, R., Valc\u00e1rcel, D., Besalduch, J., Duarte, R., Le\u00f3n, A., Pascual, M. J., Garc\u00eda-Noblejas, A., L\u00f3pez Corral, L., Xicoy, B., Sierra, J., & Schmitz, N. (2012). Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin\u2019s lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espa\u00f1ol de Linfomas\/Trasplante de M\u00e9dula Osea (GEL\/TAMO) and the lymphoma working party of the European group for blood and marrow transplantation. Haematologica,97(2), 310\u20137. https:\/\/doi.org\/10.3324\/haematol.2011.045757","journal-title":"Haematologica"},{"issue":"11","key":"10912_CR42","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.bbmt.2008.08.014","volume":"14","author":"LM Burroughs","year":"2008","unstructured":"Burroughs, L. M., O\u2019Donnell, P. V., Sandmaier, B. M., Storer, B. E., Luznik, L., Symons, H. J., Jones, R. J., Ambinder, R. F., Maris, M. B., Blume, K. G., Niederwieser, D. W., Bruno, B., Maziarz, R. T., Pulsipher, M. A., Petersen, F. B., Storb, R., Fuchs, E. J., & Maloney, D. G. (2008). Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma. Biology of Blood and Marrow Transplantation,14(11), 1279\u20131287. https:\/\/doi.org\/10.1016\/j.bbmt.2008.08.014","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"12","key":"10912_CR43","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1007\/s00277-019-03835-3","volume":"98","author":"K Izumi","year":"2019","unstructured":"Izumi, K., Kanda, J., Nishikori, M., Arai, Y., Ishikawa, T., Yoshioka, S., Ueda, Y., Maeda, T., Yonezawa, A., Anzai, N., Moriguchi, T., Imada, K., Akasaka, T., Nohgawa, M., Itoh, M., Aiba, A., Tsunemine, H., Watanabe, M., Kondo, T., & Takaori-Kondo, A. (2019). Outcomes of allogeneic stem cell transplantation for DLBCL: A multi-center study from the Kyoto stem cell transplantation group. Annals of Hematology,98(12), 2815\u20132823. https:\/\/doi.org\/10.1007\/s00277-019-03835-3","journal-title":"Annals of Hematology"},{"issue":"11","key":"10912_CR44","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood.V112.11.2173.2173","volume":"112","author":"KM Ramadani","year":"2008","unstructured":"Ramadani, K. M., Song, K. W., Connors, J. M., Al-Tourah, A., Gascoyne, R. D., Barnett, M. J., Nantel, S. H., Nevill, T. J., Shepherd, J. D., Sutherland, H. J., Lavoie, J., Forrest, D. L., Hogge, D. E., Voss, N., Brinkman, R., Abou Mourad, Y. R., Power, M. M., Narayanan, S., Smith, C. A., & Toze, C. L. (2008). Comparison of outcome between refractory\/relapsed de novo diffuse large B-cell and transformed lymphoma using related and unrelated allogeneic hematopoietic SCT. Blood,112(11), 2173.","journal-title":"Blood"},{"key":"10912_CR45","doi-asserted-by":"publisher","unstructured":"Lazarus, H. M., Zhang, M. J., Carreras, J., Hayes-Lattin, B. M., Ataergin, A. S., Bitran, J. D., Bolwell, B. J., Freytes, C. O., Gale, R. P., Goldstein, S. C., Hale, G. A., Inwards, D. J., Klumpp, T. R., Marks, D. I., Maziarz, R. T., McCarthy, P. L., Pavlovsky, S., Rizzo, J. D., Shea, T. C.,\u2026, & Hari, P. N. (2010). A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.Biology of Blood and Marrow Transplantation, 16(1), 35\u201345. https:\/\/doi.org\/10.1016\/j.bbmt.2009.08.011","DOI":"10.1016\/j.bbmt.2009.08.011"},{"issue":"3","key":"10912_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/bmt.2015.286","volume":"51","author":"SP Robinson","year":"2016","unstructured":"Robinson, S. P., Boumendil, A., Finel, H., Blaise, D., Poir\u00e9, X., Nicolas-Virelizier, E., Or, R., Malladi, R., Corby, A., Fornecker, L., Caballero, D., Pohlreich, D., Nagler, A., Thieblemont, C., Finke, J., Bachy, E., Vincent, L., Schroyens, W., Schouten, H., & Dreger, P. (2016). Autologous stem cell transplantation for relapsed\/refractory diffuse large B-cell lymphoma: Efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT lymphoma working party. Bone Marrow Transplantation,51(3), 365\u201371. https:\/\/doi.org\/10.1038\/bmt.2015.286","journal-title":"Bone Marrow Transplantation"},{"issue":"7","key":"10912_CR47","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3324\/haematol.2009.017608","volume":"95","author":"JL Pi\u00f1ana","year":"2010","unstructured":"Pi\u00f1ana, J. L., Martino, R., Gayoso, J., Sureda, A., de la Serna, J., D\u00edez-Mart\u00edn, J. L., Vazquez, L., Arranz, R., Tom\u00e1s, J. F., Sampol, A., Solano, C., Delgado, J., Sierra, J., Caballero, D., GELTAMO Group. (2010). Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: Long-term follow-up from two prospective multicenter trials. Haematologica,95(7), 1176\u201382. https:\/\/doi.org\/10.3324\/haematol.2009.017608","journal-title":"Haematologica"},{"issue":"11","key":"10912_CR48","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/bmt.2013.83","volume":"48","author":"SP Robinson","year":"2013","unstructured":"Robinson, S. P., Canals, C., Luang, J. J., Tilly, H., Crawley, C., Cahn, J. Y., Pohlreich, D., Le Gouill, S., Gilleece, M., Milpied, N., Attal, M., Biron, P., Maury, S., Rambaldi, A., Maertens, J., Capria, S., Colombat, P., Montoto, S., & Sureda, A. (2013). The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: An analysis from the lymphoma working party of the EBMT. Bone Marrow Transplantation,48(11), 1409\u20131414. https:\/\/doi.org\/10.1038\/bmt.2013.83","journal-title":"Bone Marrow Transplantation"},{"issue":"12","key":"10912_CR49","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.bbmt.2015.07.028","volume":"21","author":"E Klyuchnikov","year":"2015","unstructured":"Klyuchnikov, E., Bacher, U., Kr\u00f6ger, N. M., Hari, P. N., Ahn, K. W., Carreras, J., Bachanova, V., Bashey, A., Cohen, J. B., D\u2019Souza, A., Freytes, C. O., Gale, R. P., Ganguly, S., Hertzberg, M. S., Holmberg, L. A., Kharfan-Dabaja, M. A., Klein, A., Ku, G. H., Laport, G. G., & Hamadani, M. (2015). Reduced-intensity allografting as first transplantation approach in relapsed\/refractory grades one and two follicular lymphoma provides improved outcomes in long-term survivors. Biology of Blood and Marrow Transplantation,21(12), 2091\u20132099. https:\/\/doi.org\/10.1016\/j.bbmt.2015.07.028","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"12","key":"10912_CR50","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/annonc\/mdv473","volume":"26","author":"C Hosing","year":"2015","unstructured":"Hosing, C., Bassett, R., Dabaja, B., Talpur, R., Alousi, A., Ciurea, S., Popat, U., Qazilbash, M., Shpall, E. J., Oki, Y., Nieto, Y., Pinnix, C., Fanale, M., Maadani, F., Donato, M., Champlin, R., & Duvic, M. (2015). Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: Updated results from a single institution. Annals of Oncology,26(12), 2490\u20132495. https:\/\/doi.org\/10.1093\/annonc\/mdv473","journal-title":"Annals of Oncology"},{"issue":"2","key":"10912_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/10428194.2018.1468894","volume":"60","author":"JD Sandoval-Sus","year":"2019","unstructured":"Sandoval-Sus, J. D., Faramand, R., Chavez, J., Puri, S., Parra, P., Sokol, L., Kharfan-Dabaja, M. A., Shah, B., & Ayala, E. (2019). Allogeneic hematopoietic cell transplantation is potentially curative in mantle cell lymphoma: Results from a single institution study. Leukaemia & Lymphoma,60(2), 309\u2013316. https:\/\/doi.org\/10.1080\/10428194.2018.1468894","journal-title":"Leukaemia & Lymphoma"},{"key":"10912_CR52","doi-asserted-by":"publisher","unstructured":"Hamadani, M., Saber, W., Ahn, K. W., Carreras, J., Cairo, M. S., Fenske, T. S., Gale, R. P., Gibson, J., Hale, G. A., Hari, P. N., Hsu, J. W., Inwards, D. J., Kamble, R. T., Klein, A., Maharaj, D., Marks, D. I., Rizzieri, D. A., Savani, B. N., Schouten, H. C.,\u2026, & Lazarus, H. M. (2013). Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.Biology of Blood and Marrow Transplantation, 19(4), 625\u201331. https:\/\/doi.org\/10.1016\/j.bbmt.2013.01.009","DOI":"10.1016\/j.bbmt.2013.01.009"},{"key":"10912_CR53","doi-asserted-by":"publisher","unstructured":"Beelen, D. W., Arnold, R., Stelljes, M., Alakel, N., Brecht, A., Bug, G., Bunjes, D., Faul, C., Finke, J., Franke, G. N., Holler, E., Kobbe, G., Kr\u00f6ger, N., R\u00f6sler, W., Scheid, C., Sch\u00f6nland, S., Stadler, M., Tischer, J., Wagner-Drouet, E.,\u2026, & G\u00f6kbuget, N. (2022). Long-term results of allogeneic stem cell transplantation in adult Ph- negative high-risk acute lymphoblastic leukemia. Transplantation and Cellular Therapy, 28(12), 834\u2013842. https:\/\/doi.org\/10.1016\/j.jtct.2022.08.024","DOI":"10.1016\/j.jtct.2022.08.024"},{"issue":"2","key":"10912_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1179\/1607845414Y.0000000175","volume":"20","author":"YY Hwang","year":"2015","unstructured":"Hwang, Y. Y., Mohty, M., & Chim, C. S. (2015). Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: Myeloablative, non-myeloablative, and beyond. Hematology,20(2), 61\u201371. https:\/\/doi.org\/10.1179\/1607845414Y.0000000175","journal-title":"Hematology"},{"issue":"4","key":"10912_CR55","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/sj.bmt.1705734","volume":"40","author":"CS Chim","year":"2007","unstructured":"Chim, C. S., Lie, A. K., Liang, R., Au, W. Y., & Kwong, Y. L. (2007). Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: Favorable outcome with BMT at first remission and HLA-matched unrelated donor. Bone Marrow Transplantation,40(4), 339\u2013347. https:\/\/doi.org\/10.1038\/sj.bmt.1705734","journal-title":"Bone Marrow Transplantation"},{"key":"10912_CR56","doi-asserted-by":"publisher","unstructured":"van Gelder, M., de Wreede, L. C., Bornh\u00e4user, M., Niederwieser, D., Karas, M., Anderson, N. S., Gramatzki, M., Dreger, P., Michallet, M., Petersen, E., Bunjes, D., Potter, M., Beelen, D., Cornelissen, J. J., Yakoub-Agha, I., Russell, N. H., Finke, J., Schoemans, H., Vitek, A.,\u2026, & Schetelig, J. (2017) Long-term survival of patients with CLL after allogeneic transplantation: a report from the European society for blood and marrow transplantation.Bone Marrow Transplantation, 52(3), 372\u2013380. https:\/\/doi.org\/10.1038\/bmt.2016.282","DOI":"10.1038\/bmt.2016.282"},{"issue":"4","key":"10912_CR57","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1182\/blood-2015-03-585091","volume":"126","author":"A Mato","year":"2015","unstructured":"Mato, A., & Porter, D. L. (2015). A drive through cellular therapy for CLL in 2015: Allogeneic cell transplantation and CARs. Blood,126(4), 478\u2013485. https:\/\/doi.org\/10.1182\/blood-2015-03-585091","journal-title":"Blood"},{"issue":"6","key":"10912_CR58","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41409-023-01943-3","volume":"58","author":"JR Passweg","year":"2023","unstructured":"Passweg, J. R., Baldomero, H., Ciceri, F., Corbacioglu, S., de la C\u00e1mara, R., Dolstra, H., Glass, B., Greco, R., McLornan, D. P., Neven, B., de Latour, R. P., Peri\u0107, Z., Ruggeri, A., Snowden, J. A., & Sureda, A. (2023). Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A report from the EBMT activity survey. Bone Marrow Transplantation,58(6), 647\u2013658. https:\/\/doi.org\/10.1038\/s41409-023-01943-3","journal-title":"Bone Marrow Transplantation"},{"key":"10912_CR59","doi-asserted-by":"publisher","unstructured":"Lioure, B., B\u00e9n\u00e9, M. C., Pigneux, A., Huynh, A., Chevallier, P., Fegueux, N., Blaise, D., Witz, B., Delain, M., Cornillon, J., Luquet, I., Blanchet, O., Cornillet-Lefebvre, P., Carr\u00e9, M., Hunault, M., Larosa, F., Lamy, T., Randriamalala, E., Ojeda-Uribe, M.,\u2026, &Cahn, J. Y.; GOELAMS. (2012). Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: Long-term results of a prospective GOELAMS study. Blood, 119(12), 2943\u20138. https:\/\/doi.org\/10.1182\/blood-2011-05-352989","DOI":"10.1182\/blood-2011-05-352989"},{"issue":"6","key":"10912_CR60","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/ejh.12522","volume":"95","author":"PG Hemmati","year":"2015","unstructured":"Hemmati, P. G., Terwey, T. H., Na, I. K., Jehn, C. F., le Coutre, P., Vuong, L. G., D\u00f6rken, B., & Arnold, R. (2015). Allogeneic stem cell transplantation for refractory acute myeloid leukemia: A single center analysis of long-term outcome. European Journal of Haematology,95(6), 498\u2013506. https:\/\/doi.org\/10.1111\/ejh.12522","journal-title":"European Journal of Haematology"},{"key":"10912_CR61","doi-asserted-by":"publisher","unstructured":"Heinicke, T., Krahl, R., Kahl, C., Cross, M., Scholl, S., Wolf, H. H., H\u00e4hling, D., Hegenbart, U., Peter, N., Schulze, A., Florsch\u00fctz, A., Schmidt, V., Reifenrath, K., Zojer, N., Junghanss, C., Sayer, H. G., Maschmeyer, G., Sp\u00e4th, C., Hochhaus, A.,\u2026, & Niederwieser, D. (2021). Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials. Annals of hematology, 100(9), 2387\u20132398. https:\/\/doi.org\/10.1007\/s00277-021-04565-1","DOI":"10.1007\/s00277-021-04565-1"},{"issue":"4","key":"10912_CR62","first-page":"513","volume":"91","author":"A Gratwohl","year":"2006","unstructured":"Gratwohl, A., Brand, R., Apperley, J., Crawley, C., Ruutu, T., Corradini, P., Carreras, E., Devergie, A., Guglielmi, C., Kolb, H. J., Niederwieser, D., Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. (2006). Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: Transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica,91(4), 513\u201321.","journal-title":"Haematologica"},{"issue":"12","key":"10912_CR63","doi-asserted-by":"publisher","first-page":"768.e1","DOI":"10.1016\/j.jtct.2023.09.010","volume":"29","author":"M Ohbiki","year":"2023","unstructured":"Ohbiki, M., Ito, Y., Inamoto, Y., Miyamura, K., Uchida, N., Fukuda, T., Fujiwara, H., Nishida, T., Hayashi, M., Tanaka, M., Kawakita, T., Ikegame, K., Katayama, Y., Ara, T., Ichinohe, T., Kiyoi, H., Matsuo, K., & Atsuta, Y. (2023). Improved long-term net survival after allogeneic hematopoietic cell transplantation in patients with hematologic malignancies over two decades. Transplantation and Cellular Therapy,29(12), 768.e1-768.e10. https:\/\/doi.org\/10.1016\/j.jtct.2023.09.010","journal-title":"Transplantation and Cellular Therapy"},{"issue":"12","key":"10912_CR64","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1182\/blood-2003-06-1856","volume":"102","author":"HJ Deeg","year":"2003","unstructured":"Deeg, H. J., Gooley, T. A., Flowers, M. E., Sale, G. E., Slattery, J. T., Anasetti, C., Chauncey, T. R., Doney, K., Georges, G. E., Kiem, H. P., Martin, P. J., Petersdorf, E. W., Radich, J., Sanders, J. E., Sandmaier, B. M., Warren, E. H., Witherspoon, R. P., Storb, R., & Appelbaum, F. R. (2003). Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Blood,102(12), 3912\u20133918. https:\/\/doi.org\/10.1182\/blood-2003-06-1856","journal-title":"Blood"},{"key":"10912_CR65","doi-asserted-by":"publisher","unstructured":"Michel, C., Robin, M., Morisset, S., Blaise, D., Maertens, J., Chevalier, P., Castilla-Llorente, C., Forcade, E., Ceballos, P., Yakoug-Agha, I., Poire, X., Carre, M., Bay, J. O., Beguin, Y., Loschi, M., Huynh, A., Guillerm, G., Fran\u00e7ois, S., Mear, J. B.,\u2026, & D\u2019Aveni, M. (2023) Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS. Bone Marrow Transplantation, 58(5), 534\u2013543. https:\/\/doi.org\/10.1038\/s41409-023-01931-7","DOI":"10.1038\/s41409-023-01931-7"},{"issue":"1","key":"10912_CR66","doi-asserted-by":"publisher","first-page":"95.e1","DOI":"10.1016\/j.bbmt.2020.10.007","volume":"27","author":"N Gagelmann","year":"2021","unstructured":"Gagelmann, N., Bogdanov, R., St\u00f6lzel, F., Rautenberg, C., Panagiota, V., Becker, H., Radujkovic, A., Luft, T., Christopeit, M., Finke, J., Platzbecker, U., Ditschkowski, M., Schroeder, T., Koldehoff, M., Heuser, M., Kobbe, G., Beelen, D. W., Germing, U., & Kr\u00f6ger, N. (2021). Long-term survival benefit after allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia. Transplantation and Cellular Therapy,27(1), 95.e1-95.e4. https:\/\/doi.org\/10.1016\/j.bbmt.2020.10.007","journal-title":"Transplantation and Cellular Therapy"},{"key":"10912_CR67","doi-asserted-by":"publisher","unstructured":"Robin, M., de Wreede, L. C., Padron, E., Bakunina, K., Fenaux, P., Koster, L., Nazha, A., Beelen, D. W., Rampal, R. K., Sockel, K., Komrokji, R. S., Gagelmann, N., Eikema, D. J., Radujkovic, A., Finke, J., Potter, V., Killick, S. B., Legrand, F., Solary, E.,\u2026, & Itzykson, R. (2022). Role of allogeneic transplantation in chronic myelomonocytic leukemia: An international collaborative analysis. Blood, 140(12), 1408\u20131418. https:\/\/doi.org\/10.1182\/blood.2021015173","DOI":"10.1182\/blood.2021015173"},{"issue":"1","key":"10912_CR68","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1046\/j.1365-2141.2000.02289.x","volume":"111","author":"S Kojima","year":"2000","unstructured":"Kojima, S., Horibe, K., Inaba, J., Yoshimi, A., Takahashi, Y., Kudo, K., Kato, K., & Matsuyama, T. (2000). Long-term outcome of acquired aplastic anaemia in children: Comparison between immunosuppressive therapy and bone marrow transplantation. British Journal of Haematology,111(1), 321\u2013328. https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02289.x","journal-title":"British Journal of Haematology"},{"issue":"12","key":"10912_CR69","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3324\/haematol.2014.109355","volume":"99","author":"N Yoshida","year":"2014","unstructured":"Yoshida, N., Kobayashi, R., Yabe, H., Kosaka, Y., Yagasaki, H., Watanabe, K., Kudo, K., Morimoto, A., Ohga, S., Muramatsu, H., Takahashi, Y., Kato, K., Suzuki, R., Ohara, A., & Kojima, S. (2014). First-line treatment for severe aplastic anemia in children: Bone marrow transplantation from a matched family donor versus immunosuppressive therapy. Haematologica,99(12), 1784\u20131791. https:\/\/doi.org\/10.3324\/haematol.2014.109355","journal-title":"Haematologica"},{"issue":"17","key":"10912_CR70","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1182\/blood-2017-09-807859","volume":"131","author":"S Giammarco","year":"2018","unstructured":"Giammarco, S., Peffault de Latour, R., Sica, S., Dufour, C., Socie, G., Passweg, J., Kr\u00f6ger, N., Petersen, E., Van Lint, M. T., Oneto, R., Signori, A., Bacigalupo, A., European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party. (2018). Transplant outcome for patients with acquired aplastic anemia over the age of 40: Has the outcome improved? Blood,131(17), 199\u2013192. https:\/\/doi.org\/10.1182\/blood-2017-09-807859","journal-title":"Blood"},{"issue":"8","key":"10912_CR71","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.bbmt.2019.02.024","volume":"25","author":"L Liu","year":"2019","unstructured":"Liu, L., Liu, S., Zhang, Y., Zhou, H., Wang, Q., Tian, H., Chen, F., Qiu, H., Tang, X., Han, Y., Fu, C., Jin, Z., Chen, S., Sun, A., Miao, M., & Wu, D. (2019). Excellent outcomes of allogeneic hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria: A single-center study. Biology of Blood and Marrow Transplantation,25(8), 1544\u20131549. https:\/\/doi.org\/10.1016\/j.bbmt.2019.02.024","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"1","key":"10912_CR72","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12185-020-02982-y","volume":"113","author":"Y Nakamura","year":"2021","unstructured":"Nakamura, Y., Takenaka, K., Yamazaki, H., Onishi, Y., Ozawa, Y., Ikegame, K., Matsuoka, K. I., Toubai, T., Ueda, Y., Kanda, Y., Ichinohe, T., Atsuta, Y., & Mori, T. (2021). Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria. International Journal of Hematology,113(1), 122\u2013127. https:\/\/doi.org\/10.1007\/s12185-020-02982-y","journal-title":"International Journal of Hematology"},{"key":"10912_CR73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1182\/asheducation-2011.1.21","volume":"2011","author":"CJ Parker","year":"2011","unstructured":"Parker, C. J. (2011). Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapy. Hematology American Society of Hematology. Education Program,2011, 21\u201329. https:\/\/doi.org\/10.1182\/asheducation-2011.1.21","journal-title":"Hematology American Society of Hematology. Education Program"},{"issue":"4","key":"10912_CR74","doi-asserted-by":"publisher","first-page":"e0028","DOI":"10.5041\/RMMJ.10162","volume":"5","author":"I Henig","year":"2014","unstructured":"Henig, I., & Zuckerman, T. (2014). Hematopoietic stem cell transplantation-50 years of evolution and future perspectives. Rambam Maimonides Medical Journal,5(4), e0028. https:\/\/doi.org\/10.5041\/RMMJ.10162","journal-title":"Rambam Maimonides Medical Journal"},{"key":"10912_CR75","doi-asserted-by":"publisher","unstructured":"Schuster, S. J., Bishop, M. R., Tam, C. S., Waller, E. K., Borchmann, P., McGuirk, J. P., J\u00e4ger, U., Jaglowski, S., Andreadis, C., Westin, J. R., Fleury, I., Bachanova, V., Foley, S. R., Ho, P. J., Mielke, S., Magenau, J. M., Holte, H., Pantano, S., Pacaud, L. B.,\u2026, & Maziarz, R. T. (2019). Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. New England Journal of Medicine, 380(1), 45\u201356. https:\/\/doi.org\/10.1056\/NEJMoa1804980","DOI":"10.1056\/NEJMoa1804980"},{"key":"10912_CR76","doi-asserted-by":"publisher","unstructured":"Nastoupil, L. J., Hess, G., Pavlovsky, M. A., Danielewicz, I., Freeman, J., Garc\u00eda-Sancho, A. M., Glazunova, V., Grigg, A., Hou, J. Z., Janssens, A., Kim, S. J., Masliak, Z., McKay, P., Merli, F., Munakata, W., Nagai, H., \u00d6zcan, M., Preis, M., Wang, T.,\u2026, & Salles, G. (2023). Phase 3 SELENE study: Ibrutinib plus BR\/R-CHOP in previously treated patients with follicular or marginal zone lymphoma. Blood Advances, 7(22), 7141\u20137150. https:\/\/doi.org\/10.1182\/bloodadvances.2023010298","DOI":"10.1182\/bloodadvances.2023010298"},{"issue":"5","key":"10912_CR77","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11899-023-00700-z","volume":"18","author":"O Odetola","year":"2023","unstructured":"Odetola, O., & Ma, S. (2023). Relapsed\/refractory chronic lymphocytic leukemia (CLL). Current Hematologic Malignancy Reports,18(5), 130\u2013143. https:\/\/doi.org\/10.1007\/s11899-023-00700-z","journal-title":"Current Hematologic Malignancy Reports"},{"issue":"10","key":"10912_CR78","doi-asserted-by":"publisher","first-page":"624661","DOI":"10.3389\/fonc.2020.624661","volume":"17","author":"M Offidani","year":"2021","unstructured":"Offidani, M., Corvatta, L., Mor\u00e8, S., Nappi, D., Martinelli, G., Olivieri, A., & Cerchione, C. (2021). Daratumumab for the management of newly diagnosed and relapsed\/refractory multiple myeloma: Current and emerging treatments. Frontiers in Oncology,17(10), 624661. https:\/\/doi.org\/10.3389\/fonc.2020.624661","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10912_CR79","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","volume":"14","author":"H Liu","year":"2021","unstructured":"Liu, H. (2021). Emerging agents and regimens for AML. Journal of Hematology & Oncology,14(1), 49. https:\/\/doi.org\/10.1186\/s13045-021-01062-w","journal-title":"Journal of Hematology & Oncology"},{"issue":"6","key":"10912_CR80","doi-asserted-by":"publisher","first-page":"150951","DOI":"10.1016\/j.soncn.2019.150951","volume":"35","author":"S Gregory","year":"2019","unstructured":"Gregory, S. (2019). Adult acute lymphoblastic leukemia: Treatment and management updates. Seminars in Oncology Nursing,35(6), 150951. https:\/\/doi.org\/10.1016\/j.soncn.2019.150951","journal-title":"Seminars in Oncology Nursing"},{"key":"10912_CR81","doi-asserted-by":"publisher","unstructured":"Aubrais, R., Bouabdallah, K., Chartier, L., Herbaux, C., Banos, A., Brice, P., Sibon, D., Schiano, J. M., Cluzeau, T., Laribi, K., Le Calloch, R., Bellal, M., Delapierre, B., Daguindau, N., Amorim, S., Agbetiafa. K., Chauchet, A., Besson. C., Durot, E.,\u2026, & Damaj, G. (2023). Salvage therapy with brentuximab-vedotin and bendamustine for\u00a0patients with R\/R PTCL: A retrospective study from the LYSA group. Blood Advances, 7(19), 5733\u20135742. https:\/\/doi.org\/10.1182\/bloodadvances.2022008524","DOI":"10.1182\/bloodadvances.2022008524"},{"issue":"2","key":"10912_CR82","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1182\/bloodadvances.2021005794","volume":"6","author":"LH Sehn","year":"2022","unstructured":"Sehn, L. H., Hertzberg, M., Opat, S., Herrera, A. F., Assouline, S., Flowers, C. R., Kim, T. M., McMillan, A., Ozcan, M., Safar, V., Salles, G., Ku, G., Hirata, J., Chang, Y. M., Musick, L., & Matasar, M. J. (2022). Polatuzumab vedotin plus bendamustine and rituximab in relapsed\/refractory DLBCL: Survival update and new extension cohort data. Blood Advances,6(2), 533\u2013543. https:\/\/doi.org\/10.1182\/bloodadvances.2021005794","journal-title":"Blood Advances"},{"issue":"18","key":"10912_CR83","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.3390\/cancers15184509","volume":"15","author":"MP Randall","year":"2023","unstructured":"Randall, M. P., & Spinner, M. A. (2023). Optimizing treatment for relapsed\/refractory classic Hodgkin lymphoma in the era of immunotherapy. Cancers (Basel).,15(18), 4509. https:\/\/doi.org\/10.3390\/cancers15184509","journal-title":"Cancers (Basel)."},{"issue":"11","key":"10912_CR84","doi-asserted-by":"publisher","first-page":"752.e1","DOI":"10.1016\/j.jtct.2022.07.028","volume":"28","author":"O Pasvolsky","year":"2022","unstructured":"Pasvolsky, O., Milton, D. R., Rauf, M., Tanner, M. R., Bashir, Q., Srour, S., Tang, G., Saini, N., Ramdial, J., Masood, A., Nieto, Y., Lee, H. C., Patel, K. K., Kebriaei, P., Thomas, S. K., Weber, D. M., Orlowski, R. Z., Shpall, E. J., Champlin, R. E., & Qazilbash, M. H. (2022). Lenalidomide-based maintenance after autologous hematopoietic stem cell transplantation for patients with high-risk multiple myeloma. Transplantation and Cellular Therapy,28(11), 752.e1-752.e6. https:\/\/doi.org\/10.1016\/j.jtct.2022.07.028","journal-title":"Transplantation and Cellular Therapy"},{"issue":"5","key":"10912_CR85","doi-asserted-by":"publisher","first-page":"258.e1","DOI":"10.1016\/j.jtct.2022.01.026","volume":"28","author":"M Reinoso-Segura","year":"2022","unstructured":"Reinoso-Segura, M., Caballero-Vel\u00e1zquez, T., Herrera, P., Patriarca, F., Fanin, R., Bruno, B., Einsele, H., Nahi, H., Granell, M., L\u00f3pez-Corral, L., Reguera, J. L., Garc\u00eda-Cadenas, I., Gahrton, G., & P\u00e9rez-Sim\u00f3n, J. A. (2022). Phase II trial of allogeneic transplantation plus novel drugs in multiple myeloma: Effect of intensifying reduced-intensity conditioning with bortezomib and adding maintenance treatment. Transplantation and Cellular Therapy,28(5), 258.e1-258.e8. https:\/\/doi.org\/10.1016\/j.jtct.2022.01.026","journal-title":"Transplantation and Cellular Therapy"},{"key":"10912_CR86","doi-asserted-by":"publisher","unstructured":"Dytfeld, D., Wr\u00f3bel, T., Jamroziak, K., Kubicki, T., Robak, P., Walter-Croneck, A., Czy\u017c, J., Tyczy\u0144ska, A., Druzd-Sitek, A., Giannopoulos, K., Nowicki, A., Szczepaniak, T., \u0141ojko-Dankowska, A., Matuszak, M., Gil, L., Pu\u0142a, B., Rybka, J., Majcherek, M., Usnarska-Zubkiewicz, L.,\u2026, & Jakubowiak, A. J. (2023). Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): Interim analysis of a randomised, open-label, phase 3 trial. The Lancet Oncology, 24(2), 139\u2013150. https:\/\/doi.org\/10.1016\/S1470-2045(22)00738-0","DOI":"10.1016\/S1470-2045(22)00738-0"},{"issue":"12","key":"10912_CR87","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1038\/s41375-022-01691-1","volume":"36","author":"M Slade","year":"2022","unstructured":"Slade, M., Martin, T. G., Nathwani, N., Fiala, M. A., Rettig, M. P., Gao, F., Deol, A., Buadi, F. K., Kaufman, J. L., Hofmeister, C. C., Gregory, T. K., Berdeja, J., Chari, A., Rosko, A., & Vij, R. (2022). Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma. Leukemia,36(12), 2917\u20132921. https:\/\/doi.org\/10.1038\/s41375-022-01691-1","journal-title":"Leukemia"},{"key":"10912_CR88","doi-asserted-by":"publisher","unstructured":"Badros, A., Foster, L., Anderson, L. D. Jr., Chaulagain, C. P., Pettijohn, E., Cowan, A. J., Costello, C., Larson, S., Sborov, D. W., Shain, K. H., Silbermann, R., Shah, N., Chung, A., Krevvata, M., Pei, H., Patel. S., Khare, V., Cortoos, A., Carson, R.,\u2026, & Voorhees, P.(2025). Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study. Blood, 145(3), 300\u2013310. https:\/\/doi.org\/10.1182\/blood.2024025746","DOI":"10.1182\/blood.2024025746"},{"issue":"14","key":"10912_CR89","doi-asserted-by":"publisher","first-page":"1391743","DOI":"10.3389\/fonc.2024.1391743","volume":"24","author":"E Diral","year":"2024","unstructured":"Diral, E., Furnari, G., Bruno, A., Greco, R., Clerici, D., Marktel, S., Farina, F., Mastaglio, S., Vago, L., Piemontese, S., Peccatori, J., Corti, C., Bernardi, M., Ciceri, F., & Lupo-Stanghellini, M. T. (2024). Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: A real-world, single-center experience. Frontiers in Oncology,24(14), 1391743. https:\/\/doi.org\/10.3389\/fonc.2024.1391743","journal-title":"Frontiers in Oncology"},{"issue":"26","key":"10912_CR90","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1200\/JCO.22.02721","volume":"41","author":"KW Pratz","year":"2023","unstructured":"Pratz, K. W., Cherry, M., Altman, J. K., Cooper, B. W., Podoltsev, N. A., Cruz, J. C., Lin, T. L., Schiller, G. J., Jurcic, J. G., Asch, A., Wu, R., Hill, J. E., Gill, S. C., James, A. J., Rich, E. S., Hasabou, N., Perl, A. E., & Levis, M. J. (2023). Gilteritinib in combination with induction and consolidation chemotherapy and as maintenance therapy: A phase IB study in patients with newly diagnosed AML. Journal of Clinical Oncology,41(26), 4236\u20134246. https:\/\/doi.org\/10.1200\/JCO.22.02721","journal-title":"Journal of Clinical Oncology"},{"key":"10912_CR91","doi-asserted-by":"publisher","unstructured":"Schlenk, R. F., Montesinos, P., Kim, H. J., Romero-Aguilar, A., Vrhovac, R., Patkowska, E., \u017dak, P., Wang, P. N., Hanyok, J., Liu, L., Kamel, Y. M., Imadalou, K., Lesegretain, A., Cortes, J., Sekeres, M. A., Dombret, H., Amadori, S., Wang, J., Perl, A. E.,\u2026, & Erba, H. P.(2025). Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2024.286623","DOI":"10.3324\/haematol.2024.286623"},{"issue":"6","key":"10912_CR92","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3390\/cancers14061490","volume":"14","author":"I Abou Dalle","year":"2022","unstructured":"Abou Dalle, I., El Cheikh, J., & Bazarbachi, A. (2022). Pharmacologic strategies for post-transplant maintenance in acute myeloid leukemia: It is time to consider! Cancers (Basel).,14(6), 1490. https:\/\/doi.org\/10.3390\/cancers14061490","journal-title":"Cancers (Basel)."},{"issue":"12","key":"10912_CR93","doi-asserted-by":"publisher","first-page":"e919","DOI":"10.1016\/S2352-3026(22)00293-9","volume":"9","author":"YJ Chang","year":"2022","unstructured":"Chang, Y. J., Pei, X. Y., & Huang, X. J. (2022). Haematopoietic stem-cell transplantation in China in the era of targeted therapies: Current advances, challenges, and future directions. The Lancet Haematology,9(12), e919\u2013e929. https:\/\/doi.org\/10.1016\/S2352-3026(22)00293-9","journal-title":"The Lancet Haematology"},{"key":"10912_CR94","doi-asserted-by":"publisher","unstructured":"Sureda, A., Corbacioglu, S., Greco, R., Kr\u00f6ger, N., Carreras, E. (2024). Indications and results. The EBMT handbook: Hematopoietic cell transplantation and cellular therapies. 8th ed. Cham (CH): Springer. p. 615\u2013862. https:\/\/doi.org\/10.1007\/978-3-031-44080-9","DOI":"10.1007\/978-3-031-44080-9"},{"key":"10912_CR95","doi-asserted-by":"publisher","unstructured":"D\u00f6hner, H., Estey, E., Grimwade, D., Amadori, S., Appelbaum, F. R., B\u00fcchner, T., Dombret, H., Ebert, B. L., Fenaux, P., Larson, R. A., Levine, R. L., Lo-Coco, F., Naoe, T., Niederwieser, D., Ossenkoppele, G. J., Sanz, M., Sierra, J., Tallman, M. S., Tien, H. F.,\u2026, & Bloomfield, C. D. (2017). Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood, 129(4), 424\u2013447. https:\/\/doi.org\/10.1182\/blood-2016-08-733196","DOI":"10.1182\/blood-2016-08-733196"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10912-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-10912-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10912-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T20:36:53Z","timestamp":1757191013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-10912-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10912"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-10912-w","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"29 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}